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Abstract
For the extrapolation of data obtained from experimental animals to the human situation, it is
important to know the similarities and differences between human and animal species. Some
important characteristics of nitric oxide synthase (NOS) in myometrium and vagina from human
and rat were compared. NOS-activity was measured by the formation of 14C-citrulline from 14C-
arginine and the expression of NOS isoforms was examined by Western blotting. NOS activity in
human uterus and vagina was significantly lower than in the tissues from rat. In contrast to the rat
where NOS activity was predominantly found in the cytosolic fractions, NOS activity in particulate
and cytosolic fractions from both human myometrium and vagina was similar. Data from Western
blots confirmed that eNOS and nNOS isoforms were concentrated in the particulate and cytosolic
fractions, respectively. Estrogen treatment of rats resulted in a down regulation of uterine cytosolic
NOS activity. A down regulation of NOS in the cytosolic fraction was also seen in the human
pregnant myometrium as compared with the nonpregnant myometrium. The vaginal NOS activity
was considerably higher than the uterus in both species. In spite of some clear-cut qualitative and
other differences between human and rat tissues, there are some interesting similarities.
Downregulation in pregnancy of human uterine NOS is probably due to, at least in part, the
influence of estrogen and progesterone.
Background
During the past decade there has been a tremendous inter-
est in nitric oxide (NO), which has now come to be ac-
cepted as an important mediator of multiple cellular
function including smooth muscle relaxation. In living
cells, NO is synthesized from L-arginine via the catalytic
action of the enzyme, NO synthase (NOS). Three types of
enzymes have been identified and characterized. Two of
the three are constitutive and expressed in specific cell
types (NOS I or neuronal and NOS III or endothelial),
whereas the expression of the third isoform (NOS II or in-
ducible) can be induced by cytokines.
In the area of human reproduction, there is now consider-
able evidence albeit not conclusive suggesting that NO-
cGMP system plays an important role in uterine and feto-
placental blood flow, quiescence of myometrium and rip-
ening of cervix [1,2]. Evidence that NO has an important
role in myometrial function comes largely from studies
showing that NO has a relaxing effect on the myometrium
and this relaxation is specifically blocked by inhibitors of
NOS [3,4]. NO exerts its smooth muscle relexant effect by
stimulating soluble guanylate cyclase, thereby increasing
cyclic GMP [1–4].
Published: 6 February 2003
Reproductive Biology and Endocrinology 2003, 1:10
Received: 27 January 2003
Accepted: 6 February 2003
This article is available from: http://www.RBEj.com/content/1/1/10
© 2003 Batra et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.Page 1 of 11
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/10Several recent studies show the presence of NOS in the
uterus from animal species [5–10]. However, there appear
to be differences with respect to the predominant form,
subcellular localisation, and Ca2+ dependence in different
species. These may be due to real differences in species,
hormonal status of the animal, or methodology em-
ployed or a combination of these.
We have reported that in the non-pregnant rabbit uterus,
cytosolic NOS was the predominant form and that NOS
activity in both cytosolic and particulate fractions was
highly Ca2+-dependent indicating the presence of consti-
tutive NOS [9]. We also demonstrated for the first time
that under well-controlled conditions, there is a clear
down-regulation by estrogen of rabbit uterine and vaginal
NOS [9,10]. Interestingly, the down-regulation was seen
in cytosolic NOS, which was the predominant form, and
not particulate NOS. Similar findings were recently re-
ported in the female rat reproductive organs [11]. Interest-
ingly, in both rabbits and rats NOS activity was
considerably higher in the vagina than uterus.
There are several published studies in which NOS activity
was characterised in uterine tissue from animal species,
but there is relatively little information on human uterus
and practically none in human vaginal tissue. Although
considerable evidence suggests that NO plays an impor-
tant role in the regulation of myometrial activity, particu-
larly in maintaining uterine quiescence, the role of NO in
vaginal physiology is not known.
In our preliminary observations in human reproductive
tissues, we found NOS activity to be very low compared
with the rabbit or the rat tissues. In the present study, we
have partially characterized NOS activity in human myo-
metrium and vagina and have made qualitative and quan-
titative comparison with the data obtained in the rat
tissues. In addition, to judge the extent to which sex ster-
oids and pregnancy can influence the NOS activity, uter-
ine tissue from both pregnant and non-pregnant women
and rat tissues from ovariectomized and estrogen treated
animals were also examined.
Material and Methods
Materials
All chemicals were obtained commercially from the fol-
lowing suppliers. From Sigma-Aldrich (Stockholm, Swe-
den): Reduced β-nicotinamide adenine dinucleotide
phosphate (NADPH), flavin adenine dinucleotide (FAD),
flavin mononucleotide (FMN), calmodulin, tetrahydro-L-
biopterin (BH4), NG-methyl-L-arginine, aprotinin, dithio-
threitol (DTT), leupeptin and trypsin inhibitor. From Bio
Rad Laboratories AB (Sundbyberg, Sweden): running
buffer, sample buffer, polyvinylidene difluoride mem-
brane (PVDF), dry milk and ready gels (7.5%, 50 µl).
Standard kaleidoscope was used as a size marker for West-
ern blot. From Amersham Pharmacia Biotech AB (Uppsa-
la, Sweden): ECL-kit and Hyperfilm ECL. From Merck
Eurolab (Stockholm, Sweden): Whatman filters. From
Scandinavian Diagnostic Services (Falkenberg, Sweden):
Cruz Marker MW standard, primary polyclonal eNOS
(Santa Cruz sc-654) and nNOS (Santa Cruz sc-648) anti-
bodies and anti-rabbit IgG-HRP (Santa Cruz sc 2030).
Tissues from women
The study was approved by the local Ethics committee
(University Hospital, Lund, Sweden) and informed con-
sent was obtained from all patients.
Non-pregnant myometrium and vaginal tissues were ob-
tained from 11 women (55–65 years) in postmenopause.
Tissue samples were taken from anterior wall of the uterus
and anterior vaginal wall. Four patients had a second de-
gree of prolaps and underwent vaginal hysterectomy and
prolaps plasty. Five patients underwent only prolaps plas-
ty. The remaining two patients were operated by total hys-
terectomy and salpingooophorectomy (ovarian diseases).
Four patients had received a low dose of estriol (1 mg/
day).
Pregnant myometrial tissues from the upper margin of the
transverse section in the lower uterine segment were ob-
tained from 14 women. All patients underwent elected
Caesarean section delivery. Five women had labour with
breech presentation, whereas another five due to personal
apprehension preferred to deliver by Caesarean section.
Among the remaining four patients two had fetal macro-
somia, one had placenta praevia and one had vaginal cyst.
The incised tissues were rinsed with ice-cold saline and
frozen by immersion in liquid nitrogen and stored at -
80°C until used (within 3 weeks) for the experiment.
Tissues from rats
Using Xylacin®, 10 mg/kg (im) and Ketamin® 90 mg/kg
(im) as anaesthesia, mature female Sprague Dawley rats
weighing 150 – 200 g were bilaterally ovariectomized at
least 10 days before any further treatment. They were di-
vided into two groups consisting of 10 animals in each
group. While the control group (C) received no further
treatment, the rats in estrogen (E2)-treated group were giv-
en an injection (im) of 2 mg/kg polyestradiol phosphate
(Estradurin, Pharmacia Upjohn) dissolved in saline solu-
tion. Data from a previous study in rabbits have shown
that a single injection of polyestradiol phosphate main-
tains a steady and high level of plasma estradiol for at least
10 days [12]. The animals were killed after 7 days. The
uterus and vagina were removed and placed in ice-cold sa-
line solution. After excess fat and connective tissue had
been trimmed, the tissues were washed with the saline so-
lution, blotted dry and then weighed. Tissues were thenPage 2 of 11
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until used (within 3 weeks) for the experiments.
Measurement of NOS activity
After thawing on ice, the tissues were homogenised in ap-
proximately 10 vol. of buffer containing 320 mM sucrose,
10 mM HEPES buffer (pH 7.5), 0.1 mM EGTA, 1 mM DTT,
10 µg/ml trypsin inhibitor, 10 µg/ml leupeptin and 2 µg/
ml aprotinin with a Polytron homogenizer for four peri-
ods of 15 s (per gram tissue) with intermittent cooling
pauses of 20 s. The homogenate was centrifuged at 1000 g
for 10 min and the pellet was discarded. The supernatant
was filtered through one layer of gauze and centrifuged at
40 000 g for 45 minutes and the pellet and supernatant
were saved as particulate and cytosolic fractions,
respectively.
NOS activity was determined immediately following the
preparations of subcellular fractions by measuring the for-
mation of [14C]-L-citrulline from [14C]-L-arginine essen-
tially according to the procedure previously described
(5,6). Incubation of cytosolic fraction (40 – 60 µg pro-
tein) with 100 µl of reaction mixture containing 50 mM
K-phosphate (pH 7.5), 1.2 mM MgCl2, 0.24 mM CaCl2
(or 0.01 mM for human tissues), 50 mM valine, 0.1 mM
NADPH, 1 mM citrulline, 2 µM FAD, 2 µM FMN, 10 µM
BH4 (or 50 µM for human tissues), 50 IU/ml calmodulin,
20 µM arginine and 0.6 – 0.8 µM [14C] arginine (sp. Act
0.32 Ci/mmole). Samples were incubated for 20 min at
28°C. Reaction was terminated by removal of substrate
and dilution by addition of 1.5 ml of 1:1 (v/v) pre-washed
resin AG50W-X8, in ice-cold water, and 5 ml of distilled
water. After 10 min, 2 ml of the supernatant was removed
and radioactivity measured for quantification of [14C] cit-
rulline by liquid scintillation spectrometry. In preliminary
experiments endogenous arginine was removed by pas-
sage of cytosol over a column (1 ml) of AG50W-X-8 resin.
No significant difference between these or untreated cy-
tosol was observed.
Calculation of NOS activity
Specific NOS activity in pmol/mg protein/min is reported
as the difference between the activity (total) and activity
measured in a medium lacking CaCl2 and containing 1
mM NG-methyl-L arginine and 1 mM EGTA (non-specif-
ic). Calcium independent activity was the activity meas-
ured in the incubation mixture lacking CaCl2 and
containing 1 mM EGTA. Protein concentration in the sub-
cellular fractions was determined by the method of Peter-
son [13]. Data are expressed as mean ± SEM. Comparisons
were done by using unpaired student's t-test.
Western blots
Aliquots of 50 µl of supernatant or particulate fraction
were diluted 1:2 in electrophoresis sample buffer (62.5
nM Tris-HCL, pH 6.8, 25% glycerol, 2% SDS, 0.01%
bromophenol blue and 5% β-mercaptoethanol) to yield a
protein equalling to 10 µg/cell and 30 µg/cell for eNOS
and nNOS analysis, respectively. The samples were re-
duced by boiling for 5 min. Human placenta and rat cere-
bral cortex were used as a positive controls for eNOS and
nNOS, respectively. Sodium dodecyl sulphate-polyacryl-
amide gel electrophoresis (SDS-PAGE) was carried out on
a 7.5% polyacrylamide gel at 200 V for 30 min.
After electrophoretic transfer to a PVDF membrane at 10–
15 V for 30 min, blocking with dry milk diluted in TBS-
Tween was carried out over night at 4°C. The blots were
then incubated with primary polyclonal antibodies dilut-
ed in TBS-Tween dry milk (eNOS 1:2000 and nNOS
1:1000) for 1 h at room temperature. The blots were
rinsed in TBS-Tween for 1 × 15 min followed by 3 × 5 min
and incubated with secondary anti-rabbit IgG-HRP dilut-
ed in TBS-Tween (1:10 000) for 1 h at room temperature.
The blots were rinsed as above and the subjected to en-
hanced chemiluminescence (ECL) using the Western blot
detection system. Autoradiographic film was applied to
the blot until satisfactory exposure was obtained.
Results
Figure 1 shows NOS activity in both particulate and cy-
tosolic fractions prepared from human non-pregnant and
pregnant myometrium. Both total and Ca-independent
activities are shown. NOS activity in particulate fractions
was higher than in the cytosol for both types of tissues,
but the difference only in case of pregnant myometrium
was statistically significant (p < 0.05). Ca-independent ac-
tivity in cytosolic fraction was very low in both types of tis-
sues (< 10% of total), but it was substantial in the
particulate fractions particularly in the pregnant myo-
metrium as it was close to 50% of the total activity. The
corresponding figure for the non-pregnant myometrium
was < 15%. The activities in both cytosolic and particulate
fractions from the non-pregnant myometrium were sig-
nificantly higher than the pregnant myometrium indicat-
ing a downregulation during pregnancy. The statistical
significance of the differences being p < 0.005 and p < 0.05
for cytosolic and particulate fractions respectively.
A comparison of the myometrial activity between human
and rat is shown in figure 2. Although there were no note-
worthy difference in NOS activities in particulate fractions
of all tissues examined, the cytosolic NOS in the rat,
which in contrast to the human is the predominant form,
was 4–5-fold higher than the human tissues. This was true
for comparisons of both non-pregnant human myometri-
um with ovariectomized rat myometrium (p < 0.01) and
pregnant human myometrium and estrogenised rat myo-
metrium (p < 0.005). More interestingly, however, was the
downregulation in the cytosolic fractions in the pregnantPage 3 of 11
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NOS activity in cytosolic (hatched bars), particulate (solid bars) and Ca-independent (empty bars), fractions isolated from non-
pregnant and pregnant human myometrium. Values are means ± SEM. Significance of differences between non-pregnant and 
pregnant myometrium is shown by *(p < 0.05) and ***(p < 0.005).Page 4 of 11
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myometrium, which was also seen in cytosolic fraction of
rat myometrium following estrogen treatment. The differ-
ences in both cases were statistically significant (human, p
< 0.005 and rat, p < 0.05).
The data in Figure 3 show activity in myometrium and va-
gina from non-pregnant women and ovariectomized rats.
The NOS activity in both the vaginal and myometrial cy-
tosolic fractions from rat was 4–5-fold higher than the
corresponding fractions from human tissues and in either
Figure 2
NOS activity in cytosolic (hatched bars) and particulate (solid bars) from non-pregnant and pregnant fractions isolated from 
human pregnant myometrium and from ovariectomised control (Ovx) and estrogen treated (Est) rat myometrium. Values are 
means ± SEM. Significance of differences between non-pregnant human and ovariectomized rats is shown by (p < 0.01), and 
between pregnant human and estrogenized rat is shown by (p < 0.005).Page 5 of 11
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than myometrium (p < 0.005 in both species). NOS activ-
ity in vaginal particulate fraction from rat, but not human
was also higher than the corresponding fraction from the
myometrium (p < 0.05).
Western blotting was performed on isolated fractions
used for the measurement of NOS activity rather than the
whole tissue lysates. Data on Western blot analysis using
eNOS antibody are shown in Figure 4. The eNOS anti-
body reacted with a 133 kDa protein from human placen-
ta villi (positive control), corresponding to the size of
Figure 3
NOS activity in cytosolic (hatched bars) and particulate (solid bars) fractions isolated from non-pregnant human myometrium 
(Myo) and vagina (Vag), and rat ovariectomised rat myometrium and vagina. Values are means ± SEM. Significance of differences 
between human and rat tissues is shown by **(p < 0.01) and ***(p < 0.005).Page 6 of 11
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(Fig. 4, a), and vagina showed a specific band of 133 kDa,
corresponding to eNOS, which was detected in both par-
ticulate and cytosolic fractions of the myometrium al-
though the density of the band in particulate fraction was
much greater. Similar results were obtained in the vaginal
fractions except the band in cytosolic fraction was hardly
visible. The pattern of bands obtained in fractions from
the rat tissues was very similar (Fig. 4, b) to the human as
a clear expression of eNOS in the particulate fractions, a
faint band in cytosolic fraction of the myometrium, but
not vagina were visible.
Figure 4
Western blots of particulate (P) and cytosolic (C) fractions isolated from non-pregnant human myometrium and vagina (a) and 
ovariectomised rat myometrium and vagina (b) using an antibody directed against eNOS. The putative bands are seen at 133 
kDa corresponding to eNOS protein, for which human placental villi (Pl villi) were used as a positive control.Page 7 of 11
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Western blots of particulate (P) and cytosolic (C) fractions isolated from human (a) and rat (b) tissues using an antibody 
directed against nNOS. The bands are seen at 161 kDa corresponding to eNOS protein, for which rat cerebral cortex was 
used as a positive control.Page 8 of 11
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protein from rat cortex (positive control), corresponding
to the nNOS size (Fig. 5). With this antibody the cytosolic
fractions from both human myometrium and vagina
showed a clear band with a density that was much greater
than the band in the particulate fraction, which was none-
theless visible (Fig. 5, a).
Western blots analysis of rat tissues showed as expected a
clear presence of nNOS in the cytosolic fraction and in
eNOS in the particulate fraction (Fig. 5, b). With nNOS
antibody, a clear and distinct band was seen in the cy-
tosolic fractions and virtual absence of a band in the par-
ticulate fractions.
Discussion
Use of exactly the same method of preparation of subcel-
lular fractions and assay conditions for human and rat tis-
sues, allowed us to compare data on NOS activities and
other parameters in the two species both qualitatively and
quantitatively. Additionally, identification of NOS isofor-
ms by Western blotting on isolated subcellular fractions
provided information of subcellular distribution of eNOS
and nNOS.
Our data show that in contrast to the rat, NOS activity in
human uterus and vagina was nearly equally distributed
between cytosolic and particulate fractions. In the rat NOS
activity in the cytosolic fraction was 4–5 fold higher than
the particulate fraction for both myometrium and vagina.
In spite of the above difference in the subcellular distribu-
tion, the NOS activity in the vagina from both human and
rat was approximately 2-fold higher than in myometrium.
This was true for both particulate and cytosolic fractions.
Whereas there was no significant difference in the NOS ac-
tivity in particulate fractions from human and rat tissues,
cytosolic NOS in the rat myometrium and vagina was 4–
5 fold higher than corresponding human tissues. The very
low NOS activity in the human myometrium compared
with rat as shown here or that reported in the rabbit
previously [9,10] would suggest that myometrial NOS
does not play a pivotal role in myometrial activity in man.
In previous studies in the rabbit, we reported that NOS ac-
tivity in the vagina was nearly 4-fold higher than the my-
ometrium [9,10]. The present data in rat and human also
show a significant higher activity of NOS in vagina than
myometrium. Immunological studies have demonstrated
the presence of NOS in the vagina from human and other
species [14,15]. In our recent study we demonstrated NO-
dependent relaxation of vaginal smooth muscle together
with a rich supply of NOS containing nerves [10]. All
these observations point to a physiological role of NO in
vagina. NO may be important for the vasocongestion of
the vagina and for the relaxation of the inner vaginal wall
observed during sexual excitement [15]. Further studies
are needed to define the role of NOS in vaginal
physiology.
A comparison of NOS activity between non-pregnant and
pregnant human myometrium showed a significantly
lower NOS activity in both fractions from pregnant myo-
metrium than from the non-pregnant myometrium. Pre-
vious studies on changes in NOS activity during human
pregnancy have not provided any concrete evidence on
the role of NOS in myometrial quiescence. In one study,
no difference in either the expression or the activity of
NOS was found in the myometrium before and during
term labour [16]. In another study by the same group, in-
crease in the expression of both eNOS and nNOS during
human pregnancy was reported [17]. However, expres-
sion of NOS can not be equated with the enzymatic activ-
ity of NOS. Furthermore, quantification of expression can
not be as accurate as activity measurements. Bansal et al.
reported that the expression of iNOS in the myometrium
was higher in preterm not-in-labour patients than in la-
bour [18]. Yet in another study it was shown that the ex-
pression of myometrial NOS messenger-RNA did not
change throughout gestation or with the onset of labour
and that was true for both constitutive and inducible NOS
isoforms [19].
Assuming that cytosolic and particulate fractions repre-
sent nNOS and eNOS, respectively, which is supported by
the present data, our data show a significant downregula-
tion of both eNOS and nNOS activities in samples of my-
ometrium obtained from Caesarean sections at term
compared with the non-pregnant myometrium. Keeping
in mind the differences in the regional origin of the myo-
metrial samples obtained from Caesarean sections and
hysterectomies, it is suggested that sex steroids which
increase approximately by 20-fold (progesterone) to 80-
fold (estrogen) could contribute to the apparent down-
regulation of NOS activity in the myometrium. This is
supported by the present data showing the effect of estro-
gen on rat myometrium and our previous data on rabbits
showing a highly significant reduction of myometrial
NOS activity by estrogen and estrogen and progesterone
treatment [10]. Data from our previous studies in rabbit
and rat led to the conclusion that there were no notewor-
thy differences in the NOS activities, subcellular distribu-
tion and even the regulation by sex steroids in the two
species [10,11]. Since in a study by Weeks et al. a decline
in estradiol resulting from gonadotrophin releasing hor-
mone caused no change in myometrial NOS [20], it is
suggested that rise in both estrogen and progesterone are
required for the observed reduction of NOS at term
pregnancy.Page 9 of 11
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treatment with sex steroids led to a considerable loss of
adrenergic nerves in guinea pig and rabbit [21,22]. Similar
but less pronounced reduction of adrenergic nerves was
seen in the human uterus [23]. Assuming that such is the
case with also NO-generating nerves, the reduction of
nNOS in the pregnant human myometrium and our ob-
servation of marked reduction of nNOS which was the
predominant form in rat and rabbit myometrium follow-
ing estrogen and progesterone treatment [10,11] could be
explained by this phenomenon. However, other factors of
fetal origin being responsible for the downregulation of
NOS can not be ruled out [24,25]. A decrease in NOS ac-
tivity in the myometrium toward the end of pregnancy
probably represents a conditioning phase for the initia-
tion of parturition. Up- or downregulation of other factors
such as calcium channels, neurotransmitter receptors
[26,27], calcium ion permeability of fetal membranes
[24,25], and paracrine effects [28] or fetomaternal interac-
tion [29] would also be important in preparing the uterus
for the onset of labour. In a previous study in pregnant
rabbit, convincing evidence was presented for the pres-
ence of myometrial inhibitory factors originating in the
conceptus [30].
The present data from Western blot analysis support the
generally accepted view that nNOS and eNOS are pre-
dominantly recovered in the cytosolic and particulate sub-
cellular fractions. However, in contrast to nNOS, the
presence of which was hardly detectable in the particulate
fraction of either human or rat tissues, eNOS was clearly
detectable in the cytosolic fractions in tissues from both
rat and human. The simplest explanation for this unex-
pected observation is that cytosolic fraction is contaminat-
ed with small particles originally associated with the
particulate fraction. This contamination, which would be
expected to vary with the method of preparation, should
be given serious consideration when comparing the sub-
cellular distribution of NOS reported in various studies in
addition to consideration of difference in organs and
species.
In view of the very low NOS activity in the human myo-
metrium as compared with rat shown here or rabbit
reported previously [9,10], it is justified to importantly
consider the possibility in human pregnancy of paracrine
effects of fetal-placental NO in maintaining quiescence of
the myometrium. Furthermore, caution should be exer-
cised in explaining the role of NO in human pregnancy
based on the data from studies in animals, a point previ-
ously emphasised in relation to hormonal control of my-
ometrial function [20].
In summary our data show that in spite of some clear-cut
quantitative differences in NOS activity and subcellular
distribution, there are some interesting similarities be-
tween human and rat tissues. The vaginal NOS activity in
both species was considerably higher than the myometri-
um. In pregnancy there appears to be a down-regulation
of NOS activity in the human myometrium, which is
probably due at least in part to hormonal influence, as
substantiated with the data from rat and rabbit [9,10].
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